Normothermic ex vivo Heart Perfusion Combined With Melatonin Enhances Myocardial Protection in Rat Donation After Circulatory Death Hearts via Inhibiting NLRP3 Inflammasome-Mediated Pyroptosis
ObjectiveThe adoption of hearts from donation after circulatory death (DCD) is a promising approach for the shortage of suitable organs in heart transplantation. However, DCD hearts suffer from serious ischemia/reperfusion injury (IRI). Recent studies demonstrate that nucleotide-binding oligomerizat...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-08-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2021.733183/full |
id |
doaj-ef66cc97e02b46518e3709eb5982e9c2 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Jun Lu Liwei Xu Zifeng Zeng Chuqing Xue Jiale Li Xiong Chen Pengyu Zhou Shaoyan Lin Yuhui Liao Xianjin Du Ronghua Yang Shaoyi Zheng |
spellingShingle |
Jun Lu Liwei Xu Zifeng Zeng Chuqing Xue Jiale Li Xiong Chen Pengyu Zhou Shaoyan Lin Yuhui Liao Xianjin Du Ronghua Yang Shaoyi Zheng Normothermic ex vivo Heart Perfusion Combined With Melatonin Enhances Myocardial Protection in Rat Donation After Circulatory Death Hearts via Inhibiting NLRP3 Inflammasome-Mediated Pyroptosis Frontiers in Cell and Developmental Biology donation after circulatory death normothermic ex vivo heart perfusion melatonin heart preservation ischemia/reperfusion injury pyroptosis |
author_facet |
Jun Lu Liwei Xu Zifeng Zeng Chuqing Xue Jiale Li Xiong Chen Pengyu Zhou Shaoyan Lin Yuhui Liao Xianjin Du Ronghua Yang Shaoyi Zheng |
author_sort |
Jun Lu |
title |
Normothermic ex vivo Heart Perfusion Combined With Melatonin Enhances Myocardial Protection in Rat Donation After Circulatory Death Hearts via Inhibiting NLRP3 Inflammasome-Mediated Pyroptosis |
title_short |
Normothermic ex vivo Heart Perfusion Combined With Melatonin Enhances Myocardial Protection in Rat Donation After Circulatory Death Hearts via Inhibiting NLRP3 Inflammasome-Mediated Pyroptosis |
title_full |
Normothermic ex vivo Heart Perfusion Combined With Melatonin Enhances Myocardial Protection in Rat Donation After Circulatory Death Hearts via Inhibiting NLRP3 Inflammasome-Mediated Pyroptosis |
title_fullStr |
Normothermic ex vivo Heart Perfusion Combined With Melatonin Enhances Myocardial Protection in Rat Donation After Circulatory Death Hearts via Inhibiting NLRP3 Inflammasome-Mediated Pyroptosis |
title_full_unstemmed |
Normothermic ex vivo Heart Perfusion Combined With Melatonin Enhances Myocardial Protection in Rat Donation After Circulatory Death Hearts via Inhibiting NLRP3 Inflammasome-Mediated Pyroptosis |
title_sort |
normothermic ex vivo heart perfusion combined with melatonin enhances myocardial protection in rat donation after circulatory death hearts via inhibiting nlrp3 inflammasome-mediated pyroptosis |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Cell and Developmental Biology |
issn |
2296-634X |
publishDate |
2021-08-01 |
description |
ObjectiveThe adoption of hearts from donation after circulatory death (DCD) is a promising approach for the shortage of suitable organs in heart transplantation. However, DCD hearts suffer from serious ischemia/reperfusion injury (IRI). Recent studies demonstrate that nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome-mediated pyroptosis is a novel target to ameliorate myocardial IRI. Melatonin is shown to inhibit NLRP3 inflammasome-mediated pyroptosis. Therefore, this study is designed to verify the hypothesis that melatonin can protect the heart graft preserved with ex vivo heart perfusion (EVHP) against myocardial IRI via inhibiting NLRP3 inflammasome-mediated pyroptosis in a rat model of DCD.MethodsDonor-heart rats were randomly divided into three groups: (1) Control group: non-DCD hearts were harvested from heart-beating rats and immediately preserved with allogenic blood-based perfusate at constant flow for 105 min in the normothermic EVHP system; (2) DCD-vehicle group; and (3) DCD-melatonin group: rats were subjected to the DCD procedure with 25 min of warm ischemia injury and preserved by the normothermic EVHP system for 105 min. Melatonin (200 μmol/L) or vehicle was perfused in the cardioplegia and throughout the whole EVHP period. Cardiac functional assessment was performed every 30 min during EVHP. The level of oxidative stress, inflammatory response, apoptosis, and NLRP3 inflammasome-mediated pyroptosis of heart grafts submitted to EVHP were evaluated.ResultsTwenty five-minute warm ischemia injury resulted in a significant decrease in the developed pressure (DP), dP/dtmax, and dP/dtmin of left ventricular of the DCD hearts, while the treatment with melatonin significantly increased the DP, dP/dtmax of the left ventricular of DCD hearts compared with DCD-vehicle group. Furthermore, warm ischemia injury led to a significant increase in the level of oxidative stress, inflammatory response, apoptosis, and NLRP3 inflammasome-mediated pyroptosis in the hearts preserved with EVHP. However, melatonin added in the cardioplegia and throughout the EVHP period significantly attenuated the level of oxidative stress, inflammatory response, apoptosis, and NLRP3 inflammasome-mediated pyroptosis compared with DCD-vehicle group.ConclusionEVHP combined with melatonin post-conditioning attenuates myocardial IRI in DCD hearts by inhibiting NLRP3 inflammasome-mediated pyroptosis, which might expand the donor pool by the adoption of transplantable DCD hearts. |
topic |
donation after circulatory death normothermic ex vivo heart perfusion melatonin heart preservation ischemia/reperfusion injury pyroptosis |
url |
https://www.frontiersin.org/articles/10.3389/fcell.2021.733183/full |
work_keys_str_mv |
AT junlu normothermicexvivoheartperfusioncombinedwithmelatoninenhancesmyocardialprotectioninratdonationaftercirculatorydeathheartsviainhibitingnlrp3inflammasomemediatedpyroptosis AT liweixu normothermicexvivoheartperfusioncombinedwithmelatoninenhancesmyocardialprotectioninratdonationaftercirculatorydeathheartsviainhibitingnlrp3inflammasomemediatedpyroptosis AT zifengzeng normothermicexvivoheartperfusioncombinedwithmelatoninenhancesmyocardialprotectioninratdonationaftercirculatorydeathheartsviainhibitingnlrp3inflammasomemediatedpyroptosis AT chuqingxue normothermicexvivoheartperfusioncombinedwithmelatoninenhancesmyocardialprotectioninratdonationaftercirculatorydeathheartsviainhibitingnlrp3inflammasomemediatedpyroptosis AT jialeli normothermicexvivoheartperfusioncombinedwithmelatoninenhancesmyocardialprotectioninratdonationaftercirculatorydeathheartsviainhibitingnlrp3inflammasomemediatedpyroptosis AT xiongchen normothermicexvivoheartperfusioncombinedwithmelatoninenhancesmyocardialprotectioninratdonationaftercirculatorydeathheartsviainhibitingnlrp3inflammasomemediatedpyroptosis AT pengyuzhou normothermicexvivoheartperfusioncombinedwithmelatoninenhancesmyocardialprotectioninratdonationaftercirculatorydeathheartsviainhibitingnlrp3inflammasomemediatedpyroptosis AT shaoyanlin normothermicexvivoheartperfusioncombinedwithmelatoninenhancesmyocardialprotectioninratdonationaftercirculatorydeathheartsviainhibitingnlrp3inflammasomemediatedpyroptosis AT yuhuiliao normothermicexvivoheartperfusioncombinedwithmelatoninenhancesmyocardialprotectioninratdonationaftercirculatorydeathheartsviainhibitingnlrp3inflammasomemediatedpyroptosis AT xianjindu normothermicexvivoheartperfusioncombinedwithmelatoninenhancesmyocardialprotectioninratdonationaftercirculatorydeathheartsviainhibitingnlrp3inflammasomemediatedpyroptosis AT ronghuayang normothermicexvivoheartperfusioncombinedwithmelatoninenhancesmyocardialprotectioninratdonationaftercirculatorydeathheartsviainhibitingnlrp3inflammasomemediatedpyroptosis AT shaoyizheng normothermicexvivoheartperfusioncombinedwithmelatoninenhancesmyocardialprotectioninratdonationaftercirculatorydeathheartsviainhibitingnlrp3inflammasomemediatedpyroptosis |
_version_ |
1717815867073363968 |
spelling |
doaj-ef66cc97e02b46518e3709eb5982e9c22021-09-03T22:07:37ZengFrontiers Media S.A.Frontiers in Cell and Developmental Biology2296-634X2021-08-01910.3389/fcell.2021.733183733183Normothermic ex vivo Heart Perfusion Combined With Melatonin Enhances Myocardial Protection in Rat Donation After Circulatory Death Hearts via Inhibiting NLRP3 Inflammasome-Mediated PyroptosisJun Lu0Liwei Xu1Zifeng Zeng2Chuqing Xue3Jiale Li4Xiong Chen5Pengyu Zhou6Shaoyan Lin7Yuhui Liao8Xianjin Du9Ronghua Yang10Shaoyi Zheng11Department of Cardiovascular Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, ChinaDepartment of Cardiovascular Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, ChinaDepartment of Cardiovascular Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, ChinaDepartment of Cardiovascular Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, ChinaDepartment of Cardiovascular Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, ChinaDepartment of Cardiovascular Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, ChinaDepartment of Cardiovascular Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, ChinaDepartment of Cardiovascular Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, ChinaMolecular Diagnosis and Treatment Center for Infectious Diseases, Dermatology Hospital, Southern Medical University, Guangzhou, ChinaDepartment of Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan, ChinaDepartment of Burn Surgery, The First People’s Hospital of Foshan, Foshan, ChinaDepartment of Cardiovascular Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, ChinaObjectiveThe adoption of hearts from donation after circulatory death (DCD) is a promising approach for the shortage of suitable organs in heart transplantation. However, DCD hearts suffer from serious ischemia/reperfusion injury (IRI). Recent studies demonstrate that nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome-mediated pyroptosis is a novel target to ameliorate myocardial IRI. Melatonin is shown to inhibit NLRP3 inflammasome-mediated pyroptosis. Therefore, this study is designed to verify the hypothesis that melatonin can protect the heart graft preserved with ex vivo heart perfusion (EVHP) against myocardial IRI via inhibiting NLRP3 inflammasome-mediated pyroptosis in a rat model of DCD.MethodsDonor-heart rats were randomly divided into three groups: (1) Control group: non-DCD hearts were harvested from heart-beating rats and immediately preserved with allogenic blood-based perfusate at constant flow for 105 min in the normothermic EVHP system; (2) DCD-vehicle group; and (3) DCD-melatonin group: rats were subjected to the DCD procedure with 25 min of warm ischemia injury and preserved by the normothermic EVHP system for 105 min. Melatonin (200 μmol/L) or vehicle was perfused in the cardioplegia and throughout the whole EVHP period. Cardiac functional assessment was performed every 30 min during EVHP. The level of oxidative stress, inflammatory response, apoptosis, and NLRP3 inflammasome-mediated pyroptosis of heart grafts submitted to EVHP were evaluated.ResultsTwenty five-minute warm ischemia injury resulted in a significant decrease in the developed pressure (DP), dP/dtmax, and dP/dtmin of left ventricular of the DCD hearts, while the treatment with melatonin significantly increased the DP, dP/dtmax of the left ventricular of DCD hearts compared with DCD-vehicle group. Furthermore, warm ischemia injury led to a significant increase in the level of oxidative stress, inflammatory response, apoptosis, and NLRP3 inflammasome-mediated pyroptosis in the hearts preserved with EVHP. However, melatonin added in the cardioplegia and throughout the EVHP period significantly attenuated the level of oxidative stress, inflammatory response, apoptosis, and NLRP3 inflammasome-mediated pyroptosis compared with DCD-vehicle group.ConclusionEVHP combined with melatonin post-conditioning attenuates myocardial IRI in DCD hearts by inhibiting NLRP3 inflammasome-mediated pyroptosis, which might expand the donor pool by the adoption of transplantable DCD hearts.https://www.frontiersin.org/articles/10.3389/fcell.2021.733183/fulldonation after circulatory deathnormothermic ex vivo heart perfusionmelatoninheart preservationischemia/reperfusion injurypyroptosis |